tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XENE Stock Latest News

Xenon Pharmaceuticals assumed with an Overweight at Wells Fargo
The FlyXenon Pharmaceuticals assumed with an Overweight at Wells Fargo
8d ago
XENE
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Promise
PremiumCompany Announcements
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Promise
10d ago
XENE
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
PremiumCompany Announcements
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
12d ago
XENE
Xenon: Promising Outlook with Strong Financial Health and Expanding Research Initiatives
PremiumRatings
Xenon: Promising Outlook with Strong Financial Health and Expanding Research Initiatives
27d ago
XENE
Xenon Pharmaceuticals price target lowered to $55 from $57 at RBC Capital
PremiumThe Fly
Xenon Pharmaceuticals price target lowered to $55 from $57 at RBC Capital
30d ago
XENE
Xenon’s Promising Pipeline and Strategic Progress Justify Buy Rating
PremiumRatingsXenon’s Promising Pipeline and Strategic Progress Justify Buy Rating
30d ago
XENE
Xenon Pharmaceuticals: Promising Clinical Developments and Strategic Positioning Support Buy Rating
Premium
Ratings
Xenon Pharmaceuticals: Promising Clinical Developments and Strategic Positioning Support Buy Rating
30d ago
XENE
Xenon Pharmaceuticals: Promising Clinical Pipeline and Strategic Progress Justify Buy Rating
Premium
Ratings
Xenon Pharmaceuticals: Promising Clinical Pipeline and Strategic Progress Justify Buy Rating
30d ago
XENE
Xenon Pharmaceuticals Reports Q2 2025 Progress and Outlook
PremiumCompany Announcements
Xenon Pharmaceuticals Reports Q2 2025 Progress and Outlook
1M ago
XENE
Xenon Completes Patient Recruitment for Phase 3 Study
PremiumCompany Announcements
Xenon Completes Patient Recruitment for Phase 3 Study
1M ago
8K
XENE
Xenon Pharmaceuticals reports Q2 EPS $1.07 vs. (75c) last year
PremiumThe Fly
Xenon Pharmaceuticals reports Q2 EPS $1.07 vs. (75c) last year
1M ago
XENE
XENE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
XENE Earnings this Week: How Will it Perform?
1M ago
XENE
Xenon Pharmaceuticals to Announce Q2 2025 Financial Results
PremiumCompany AnnouncementsXenon Pharmaceuticals to Announce Q2 2025 Financial Results
1M ago
XENE
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
Premium
Company Announcements
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
1M ago
XENE
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call
Premium
The Fly
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call
2M ago
NPCE
RAPP
Xenon Appoints CEO Ian Mortimer as Interim CFO
PremiumCompany Announcements
Xenon Appoints CEO Ian Mortimer as Interim CFO
2M ago
8K
XENE
FDA flags possible safety signals in new report, says RBC Capital
PremiumThe Fly
FDA flags possible safety signals in new report, says RBC Capital
2M ago
ALKS
ARGX
Optimistic Buy Rating for Xenon Pharmaceuticals Driven by Promising Phase 2 Results of Azetukalner
PremiumRatings
Optimistic Buy Rating for Xenon Pharmaceuticals Driven by Promising Phase 2 Results of Azetukalner
2M ago
XENE
Xenon Pharmaceuticals Joins Russell 3000® and 2000® Indexes
PremiumCompany Announcements
Xenon Pharmaceuticals Joins Russell 3000® and 2000® Indexes
3M ago
XENE
Xenon Pharmaceuticals joins Russell 3000, Russell 2000 Indexes
PremiumThe FlyXenon Pharmaceuticals joins Russell 3000, Russell 2000 Indexes
3M ago
XENE
Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees
Premium
Company Announcements
Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees
3M ago
XENE
Xenon Pharmaceuticals Appoints Darren Cline as Chief Commercial Officer to Drive Commercial Launch
Premium
Company Announcements
Xenon Pharmaceuticals Appoints Darren Cline as Chief Commercial Officer to Drive Commercial Launch
3M ago
XENE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >